Dr. Lam Siu Ling Karen - Endocrinology, Diabetes & Metabolism
Highlights
- MCHK RegisteredVerified
- 1 LocationsWong Chuk Hang
- Specialist in Endocrinology, Diabetes & MetabolismBachelor of Medicine and Bachelor of Surgery (MBBS) · Member of the Royal Colleges of Physicians of the United Kingdom · Doctor of Medicine (MD) · Medical degree 1976
- InsuranceBeing compiled|See details
About
Dr. Lam Siu Ling Karen practises Endocrinology, Diabetes & Metabolism in Wong Chuk Hang, Hong Kong.
Education
- Bachelor of Medicine and Bachelor of Surgery (MBBS)Bachelor of Medicine and Bachelor of Surgery (MBBS)1976
- Member of the Royal Colleges of Physicians of the United KingdomMember of the Royal Colleges of Physicians of the United Kingdom1980
- Doctor of Medicine (MD)Doctor of Medicine (MD)1990
- Fellow of the Royal College of Physicians of EdinburghFellow of the Royal College of Physicians of Edinburgh1990
- FHKCPFellow, Hong Kong College of Physicians1993
Source: Hong Kong Academy of Medicine Fellows Register, checked 12 Sep 2026
Locations
Insurance
We're collecting insurance plan data per clinic. For confirmation, contact the clinic directly.
Are you Dr. Lam Siu Ling Karen? Claim page and update insurance →
FAQ
Research and publications
61 papers · 12 most recent shown
Filter by paper topic
Topics come from medical classifications on these PubMed papers, not from the doctor's listed services.
- The impact of the Lancet Commission definition of obesity on its prevalence and implications on long-term cardiovascular-kidney-metabolic outcomes in East Asians: Observational study of two community-based cohorts.PLoS medicine · 2026
- Type 2 Diabetes Is Associated With Increased Complications and Mortality After Hip Fracture in Older Adults Aged 60 Years or Older.Diabetes, obesity & metabolism · 2026
- Metabolic signatures and machine learning identify gut-liver-heart axis dysfunction as a potential link to major adverse cardiovascular events in coronary artery disease.Cardiovascular diabetology. Endocrinology reports · 2026
- Associations of Cardiovascular-Kidney-Metabolic Syndrome With All-Cause and Cardiovascular Death and the Progression of Cardiovascular-Kidney-Metabolic Syndrome Among Hong Kong Chinese People Over 2 Decades.Journal of the American Heart Association · 2026
- Author Correction: Adipose-targeted triiodothyronine therapy counteracts obesity-related metabolic complications and atherosclerosis with negligible side effects.Nature communications · 2026
- Benefits of combining SGLT2 inhibitors and pioglitazone on risk of MASH in type 2 diabetes-A real-world study.Diabetes, obesity & metabolism · 2025
- A missense variant in SLC12A3 gene enhances aberrant splicing causing Gitelman syndrome.Clinica chimica acta; international journal of clinical chemistry · 2025
- Thyroid dysfunction in COVID-19.Nature reviews. Endocrinology · 2024
- Liver-specific adiponectin gene therapy suppresses microglial NLRP3-inflammasome activation for treating Alzheimer's disease.Journal of neuroinflammation · 2024
- A clinicopathological study of non-functioning pituitary neuroendocrine tumours using the World Health Organization 2022 classification.Frontiers in endocrinology · 2024
- Serum thrombospondin-2 level changes with liver stiffness improvement in patients with type 2 diabetes.Clinical endocrinology · 2024
- General and sex-specific effects of vitamin D against atrial fibrillation and young-onset ischemic stroke: a Mendelian randomization series.Journal of clinical biochemistry and nutrition · 2024
Publication data comes from PubMed / Europe PMC and is matched automatically by name and affiliation. Every entry links to the source.
Elsewhere on the web
Hospital pages
These links are matched automatically by the doctor's name and are not confirmed by the doctor. Names repeat in Hong Kong — open a link to check.
For reference only. Not medical advice. Read full disclaimer